Observational Trial to Predict Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Observational Trial to Predict Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Conditions:   Non Small Cell Lung Cancer;   Metastatic Non Small Cell Lung Cancer;   NSCLC;   Metastatic NSCLC – Non-Small Cell Lung Cancer
Intervention:   Procedure: Core needle biopsy
Sponsor:   Elephas
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 29, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments